European Institute of Oncology / Istituto Europeo di Oncologia (IEO)
Research / Science organisation
Location:
Milano / Mailand,
Italy (IT)
ISNI: 0000000417570843
ROR: https://ror.org/02vr0ne26
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy (2020)
Mazzola R, Jereczek-Fossa BA, Franceschini D, Tubin S, Filippi AR, Tolia M, Lancia A, et al.
Journal article, Review article
Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020)
Erber R, Hartmann A, Fasching P, Stöhr R, Beckmann M, Zentgraf M, Rübner M, et al.
Conference contribution
Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party (2020)
Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, De Rosa L, et al.
Journal article
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US (2019)
Whichello C, Van Overbeeke E, Janssens R, Bywall KS, Russo S, Veldwijk J, Cleemput I, et al.
Journal article
Tumour mutational burden analysis: implementation in routine diagnostics (2019)
Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al.
Conference contribution
Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party (2019)
Bazarbachi A, Labopin M, Angelucci E, Gulbas Z, Ozdogu H, Arat M, De Rosa L, et al.
Conference contribution
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials (2019)
Yao J, Garg A, Chen D, Capdevila J, Engstrom P, Pommier R, Van Cutsem E, et al.
Journal article
Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study (2019)
Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Draeger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, et al.
Journal article
Relationship Between Metabolic Toxicity and Efficacy of Everolimus in Patients With Neuroendocrine Tumors (NETs): A Pooled Analysis From the Randomized, Phase 3 RADIANT-3, and RADIANT-4 Trials (2019)
Fazio N, Carnaghi C, Valle JW, Herbst F, Ridolfi A, Strosberg J, Kulke MH, et al.
Conference contribution
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA (2019)
Janssens R, Russo S, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, et al.
Journal article